FDA Adverse Event Other Summary report: N

ERBE VIO 300 D

MDR report key: 4834976 · Received June 1, 2015

Report

Report Number
9610614-2015-00006
Event Type
Other
Date Received
June 1, 2015
Date of Event
April 22, 2015
Report Date
June 1, 2015
Manufacturer
ERBE ELEKTROMEDIZIN GMBH
Product Code
GEI
PMA / PMN Number
K083452
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

THE ESU WAS THOROUGHLY INSPECTED/TESTED. A TECHNICAL SAFETY CHECK WAS PERFORMED ON THE GENERATOR. THIS INCLUDED AN ELECTRICAL SAFETY CHECK, A FUNCTION CHECK OF EACH OF THE EQUIPMENT'S FEATURES, AND A POWER OUTPUT CHECK. ALL FEATURES WERE/ARE FUNCTIONING PROPERLY WITHIN SPECIFICATIONS FOR THE DEVICE. NO ANOMALIES WERE FOUND IN THE REVIEW OF THE UNIT'S DEVICE HISTORY RECORD (DHR). IN CONCLUSION, NO EQUIPMENT PROBLEM WAS FOUND THAT WOULD HAVE CAUSED OR CONTRIBUTED TO THE EVENT. MOST LIKELY THERE WERE MANY FACTORS INVOLVED WITH THE PT INCIDENT SUCH AS THE PROCEDURE BEING LONG, ELDERLY/OBESE PT'S BEING MORE SUSCEPTIBLE TO PRESSURE TO THE SKIN, POSSIBLE REACTION TO DISINFECTANT USED AT THE SITE, ETC. HOWEVER, NO CONCLUSIVE DETERMINATION COULD BE MADE AS TO THE CAUSE OF THE EVENT. NO TRENDS HAVE BEEN IDENTIFIED WITH THIS INCIDENT. ERBE USA, INC IS NOW CLOSING THE FILE ON THIS EVENT.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PT INCIDENT OCCURRED DURING A KNEE ENDOPROSTHESIS WITH THE ELECTROSURGICAL UNIT (ESU/GENERATOR). THE PT WAS IN A SUNPINE POSITION DURING THE SURGERY AND THE SURGERY WAS APPROXIMATELY 100 MINUTES IN DURATION. UPON THE RIGHT KNEE REPLACEMENT ON AN OBESE PT, NECROSIS WAS DISCOVERED ON THE PT'S BUTTOCKS. NO FURTHER INFO REGARDING THE PT WAS PROVIDED. NOTE: THE ESU WAS DISTRIBUTED BY OUR PARENT COMPANY (ERBE ELECTROMEDIZIN (B)(4)) TO A (B)(6) HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
354137 ERBE VIO 300 D ELECTROSURGICAL GEI ERBE ELEKTROMEDIZIN GMBH VIO 300 D NA

Patients

Seq Age Sex Outcome Treatment
1 79 YR Other